Aspirin, Primary prevention, Racial disparities, Cardiovascular disease, Systematic Review
urinary test, urinary biomarker, point-of-care test, ROC analysis, L-FABP, COVID-19, prediction
Percutaneous coronary intervention, Dual antiplatelet therapy, Aspirin, Clopidogrel, Cardiovascular event